|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ASXL2-MORC3 (FusionGDB2 ID:7401) |
Fusion Gene Summary for ASXL2-MORC3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ASXL2-MORC3 | Fusion gene ID: 7401 | Hgene | Tgene | Gene symbol | ASXL2 | MORC3 | Gene ID | 55252 | 23515 |
Gene name | ASXL transcriptional regulator 2 | MORC family CW-type zinc finger 3 | |
Synonyms | ASXH2|SHAPNS | NXP2|ZCW5|ZCWCC3 | |
Cytomap | 2p23.3 | 21q22.12 | |
Type of gene | protein-coding | protein-coding | |
Description | putative Polycomb group protein ASXL2additional sex combs like 2, transcriptional regulatoradditional sex combs-like protein 2polycomb group protein ASXH2 | MORC family CW-type zinc finger protein 3nuclear matrix protein 2nuclear matrix protein NXP2zinc finger CW-type coiled-coil domain protein 3zinc finger, CW type with coiled-coil domain 3 | |
Modification date | 20200313 | 20200320 | |
UniProtAcc | Q76L83 | Q14149 | |
Ensembl transtripts involved in fusion gene | ENST00000435504, ENST00000336112, ENST00000272341, ENST00000404843, ENST00000497092, | ENST00000400485, ENST00000487909, | |
Fusion gene scores | * DoF score | 18 X 11 X 10=1980 | 8 X 11 X 4=352 |
# samples | 24 | 11 | |
** MAII score | log2(24/1980*10)=-3.04439411935845 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(11/352*10)=-1.67807190511264 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ASXL2 [Title/Abstract] AND MORC3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ASXL2(26101035)-MORC3(37744672), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ASXL2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway | 21047783 |
Hgene | ASXL2 | GO:0045600 | positive regulation of fat cell differentiation | 21047783 |
Hgene | ASXL2 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 21047783 |
Tgene | MORC3 | GO:0006468 | protein phosphorylation | 17332504 |
Tgene | MORC3 | GO:0007569 | cell aging | 17332504 |
Tgene | MORC3 | GO:0018105 | peptidyl-serine phosphorylation | 17332504 |
Tgene | MORC3 | GO:0048147 | negative regulation of fibroblast proliferation | 17332504 |
Tgene | MORC3 | GO:0050821 | protein stabilization | 17332504 |
Tgene | MORC3 | GO:0051457 | maintenance of protein location in nucleus | 17332504 |
Fusion gene breakpoints across ASXL2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across MORC3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-HC-A6AN-01A | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + |
Top |
Fusion Gene ORF analysis for ASXL2-MORC3 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000435504 | ENST00000400485 | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + |
5CDS-3UTR | ENST00000435504 | ENST00000487909 | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + |
5UTR-3CDS | ENST00000336112 | ENST00000400485 | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + |
5UTR-3UTR | ENST00000336112 | ENST00000487909 | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + |
5UTR-3CDS | ENST00000272341 | ENST00000400485 | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + |
5UTR-3UTR | ENST00000272341 | ENST00000487909 | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + |
intron-3CDS | ENST00000404843 | ENST00000400485 | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + |
intron-3UTR | ENST00000404843 | ENST00000487909 | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + |
intron-3CDS | ENST00000497092 | ENST00000400485 | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + |
intron-3UTR | ENST00000497092 | ENST00000487909 | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000435504 | ASXL2 | chr2 | 26101035 | - | ENST00000400485 | MORC3 | chr21 | 37744672 | + | 2013 | 351 | 153 | 662 | 169 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000435504 | ENST00000400485 | ASXL2 | chr2 | 26101035 | - | MORC3 | chr21 | 37744672 | + | 0.005167844 | 0.99483216 |
Top |
Fusion Genomic Features for ASXL2-MORC3 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
ASXL2 | chr2 | 26101034 | - | MORC3 | chr21 | 37744671 | + | 8.33E-05 | 0.9999167 |
ASXL2 | chr2 | 26101034 | - | MORC3 | chr21 | 37744671 | + | 8.33E-05 | 0.9999167 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ASXL2-MORC3 |
Go to FGviewer for the breakpoints of chr2:26101035-chr21:37744672 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ASXL2 | MORC3 |
FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development. PcG proteins are not required to initiate repression, but to maintain it during later stages of development. They probably act via methylation of histones, rendering chromatin heritably changed in its expressibility (By similarity). Involved in transcriptional regulation mediated by ligand-bound nuclear hormone receptors, such as peroxisome proliferator-activated receptor gamma (PPARG). Acts as coactivator for PPARG and enhances its adipocyte differentiation-inducing activity; the function seems to involve differential recruitment of acetylated and methylated histone H3. {ECO:0000250, ECO:0000269|PubMed:21047783}. | FUNCTION: Nuclear factor which forms MORC3-NBs (nuclear bodies) via an ATP-dependent mechanism (PubMed:20501696). Sumoylated MORC3-NBs can also associate with PML-NBs (PubMed:20501696). Recruits TP53 and SP100 to PML-NBs, thus regulating TP53 activity (PubMed:17332504). Binds RNA in vitro (PubMed:11927593). May be required for influenza A transcription during viral infection (PubMed:26202233). Histone methylation reader which binds to non-methylated (H3K4me0), monomethylated (H3K4me1), dimethylated (H3K4me2) and trimethylated (H3K4me3) 'Lys-4' on histone H3 (PubMed:26933034). The order of binding preference is H3K4me3 > H3K4me2 > H3K4me1 > H3K4me0 (PubMed:26933034). {ECO:0000269|PubMed:11927593, ECO:0000269|PubMed:17332504, ECO:0000269|PubMed:20501696, ECO:0000269|PubMed:26202233, ECO:0000269|PubMed:26933034}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000272341 | - | 1 | 13 | 1173_1176 | 0 | 919.0 | Compositional bias | Note=Poly-Ser |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000272341 | - | 1 | 13 | 303_307 | 0 | 919.0 | Compositional bias | Note=Poly-Leu |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000272341 | - | 1 | 13 | 654_684 | 0 | 919.0 | Compositional bias | Note=Ala-rich |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000272341 | - | 1 | 13 | 687_739 | 0 | 919.0 | Compositional bias | Note=Gly-rich |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000272341 | - | 1 | 13 | 95_235 | 0 | 919.0 | Compositional bias | Note=Ser-rich |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000404843 | - | 1 | 10 | 1173_1176 | 0 | 919.0 | Compositional bias | Note=Poly-Ser |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000404843 | - | 1 | 10 | 303_307 | 0 | 919.0 | Compositional bias | Note=Poly-Leu |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000404843 | - | 1 | 10 | 654_684 | 0 | 919.0 | Compositional bias | Note=Ala-rich |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000404843 | - | 1 | 10 | 687_739 | 0 | 919.0 | Compositional bias | Note=Gly-rich |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000404843 | - | 1 | 10 | 95_235 | 0 | 919.0 | Compositional bias | Note=Ser-rich |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000435504 | - | 1 | 13 | 1173_1176 | 19.0 | 1436.0 | Compositional bias | Note=Poly-Ser |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000435504 | - | 1 | 13 | 303_307 | 19.0 | 1436.0 | Compositional bias | Note=Poly-Leu |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000435504 | - | 1 | 13 | 654_684 | 19.0 | 1436.0 | Compositional bias | Note=Ala-rich |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000435504 | - | 1 | 13 | 687_739 | 19.0 | 1436.0 | Compositional bias | Note=Gly-rich |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000435504 | - | 1 | 13 | 95_235 | 19.0 | 1436.0 | Compositional bias | Note=Ser-rich |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000272341 | - | 1 | 13 | 11_86 | 0 | 919.0 | Domain | HTH HARE-type |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000272341 | - | 1 | 13 | 274_383 | 0 | 919.0 | Domain | DEUBAD |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000404843 | - | 1 | 10 | 11_86 | 0 | 919.0 | Domain | HTH HARE-type |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000404843 | - | 1 | 10 | 274_383 | 0 | 919.0 | Domain | DEUBAD |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000435504 | - | 1 | 13 | 11_86 | 19.0 | 1436.0 | Domain | HTH HARE-type |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000435504 | - | 1 | 13 | 274_383 | 19.0 | 1436.0 | Domain | DEUBAD |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000272341 | - | 1 | 13 | 174_178 | 0 | 919.0 | Motif | Nuclear localization signal |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000272341 | - | 1 | 13 | 887_891 | 0 | 919.0 | Motif | Note=LXXLL motif 2 |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000404843 | - | 1 | 10 | 174_178 | 0 | 919.0 | Motif | Nuclear localization signal |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000404843 | - | 1 | 10 | 887_891 | 0 | 919.0 | Motif | Note=LXXLL motif 2 |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000435504 | - | 1 | 13 | 174_178 | 19.0 | 1436.0 | Motif | Nuclear localization signal |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000435504 | - | 1 | 13 | 887_891 | 19.0 | 1436.0 | Motif | Note=LXXLL motif 2 |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000272341 | - | 1 | 13 | 1397_1434 | 0 | 919.0 | Zinc finger | Note=PHD-type%3B atypical |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000404843 | - | 1 | 10 | 1397_1434 | 0 | 919.0 | Zinc finger | Note=PHD-type%3B atypical |
Hgene | ASXL2 | chr2:26101035 | chr21:37744672 | ENST00000435504 | - | 1 | 13 | 1397_1434 | 19.0 | 1436.0 | Zinc finger | Note=PHD-type%3B atypical |
Tgene | MORC3 | chr2:26101035 | chr21:37744672 | ENST00000400485 | 14 | 17 | 686_877 | 836.0 | 940.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | MORC3 | chr2:26101035 | chr21:37744672 | ENST00000400485 | 14 | 17 | 326_353 | 836.0 | 940.0 | Region | Nuclear matrix binding | |
Tgene | MORC3 | chr2:26101035 | chr21:37744672 | ENST00000400485 | 14 | 17 | 500_591 | 836.0 | 940.0 | Region | RNA binding | |
Tgene | MORC3 | chr2:26101035 | chr21:37744672 | ENST00000400485 | 14 | 17 | 404_454 | 836.0 | 940.0 | Zinc finger | CW-type |
Top |
Fusion Gene Sequence for ASXL2-MORC3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000435504_ENST00000400485_TCGA-HC-A6AN-01A_ASXL2_chr2_26101035_-_MORC3_chr21_37744672_length(transcript)=2013nt_BP=351nt ACAGTAGTGACGGCCGCGCGGGAGCGGTCACATGACCGTAGCGGCAGCCTGTACAGTAAGAACCCAATATGGCAGCGGCGGTAGCAGTGG CAACGGCAGCAAGAGGACCGGCCGCCCCATAGACCCCCCCGCGCACCACCCCCGCCGCTTCCTCTGCTTGGGTGCCCCCCCGGTCTGACT TCCCTTTTCTCCCACCTTTCCCGGCACCGCGGGAAAAGCAGCGCAGGGCAGAGCAGGCAGGGAGGGCGGCCGGAGCCCGGACACGGGAGC CTCCCAGTCAGTTCAAGACCCGACATGAGGGAAAAGGGACGTAGGAAGAAGGGCAGGACCTGGGCGGAGGCCGCCAAGACGGTTGAATTG CTGGAAATGGAAAAGTCACAAATCCGTTCACAGTGTGAAGAACTCAAAACTGAAGTAGAACAGTTAAAATCTACAAATCAACAGACGGCA ACAGATGTTTCAACATCAAGTAACATTGAGGAGTCTGTAAATCATATGGATGGAGAAAGCCTCAAACTCCGATCTCTTCGAGTTAACGTA GGACAACTGCTGGCTATGATTGTGCCTGATCTTGATCTTCAGCAAGTGAATTACGATGTTGATGTAGTTGATGAGATTTTAGGACAAGTT GTTGAACAAATGAGTGAAATCAGTAGTACTTAAAGTATATGTTATGTAAGATAAAATATTTGCTCAATTCTTTTGGTTGTACAGCTTTCA AAATATAATTAATTTTGTTTTATAGATATGATAGGCAACAGACTGAAAACCATAATCTTTACTGTATTCTATGCATTCAAATGTGGTCAC AAATATTGTGGACACATTATCTTATGTTTTGAAATACCTGTGAATTGTTGGCATTGAGCAGCTGAAGCTAACTCATGACTCTGTTTTGAA TGTAAATATTTGTAATTAAGCCTGCACATATTTTTTTATTGCCCTAGAGTACTCAAGTGTTTTTCACCAAGAGCTTTTCAGGTTGCCCCT AAGCTTTGTGCAATTTTTTCTGGTTCCCCAAAGTGTATTTTTCTCTAAGTCGAGGGCTATGCCATAATACAAATGGAAATGTTACCTTTG ATTTTCTTATAAAGGAGTTTAAATAGGATTTTTAAATAATGTAGTAACACTCCTGATACAACTCTGGTTATAAGTGAATTGAGCATTAAT GTTTCTTTTGTATAAATTCCTGTCCTGAAATATTTTATTCATGAAAATAAGGTAAGCAAAAACCAACTCCATTTTGCCAGGATTTTGTTG TGCTGAGATTGCCAATCACGGTTAAACACAAAGTGTTTTTATAGAATGAAGAAACAGTCTTTAACAGAAAAAAGGTATTGAAATATTAAA TGGCCACCAAGTTTACTTTGAAGCCCATTTTTGGCTGTTTAGTCAGCATGAAGTGGGCATGATAATTTTTTAATATTTCTTTTTGTGAAA TTTCCTGTACAGCCTTTTGTAGGATTACTACAGGTTAATGTGAGTTGAGGAAGACAGTCTTTCTCAAACAATACTACATACCTTTTATTA TATTACAAACCTAAGTGTTTTATATCCTAGAGTCAAGGAACAAATTTCCTTAGGATTATAGTATTACATGCCATAAAATACTATGCTTTA TTGGTCCCATGTTTTGTGCAATTTTAAAGAGATGGCTTTCTATTAAGTATAAACTATGTATATATAAGAACCATATTTTCCACAACTAAA ATGTGCATTATTTTTTCCAAAGTTTTATCATTGCTATTTATTTTTACCTTTGTTTTTGAACATTCAATCCGTTCATTTTGTATGTATGCT TAATACGTGTCGGTCATATACAGTATTGAATTTTTACTGTATAGTAATTCTGGAAAGAGCAAATAAATGAAGATTGTTTTTATTTGCCTG ATAAAGTAATTGAAAGTGTATTTTTGGTATGAAGCTGGTTTTCTGTCACAATTGTAATTTCCCAAATTTTAAAATATCTTATAATAAAAT >In-frame_ENST00000435504_ENST00000400485_TCGA-HC-A6AN-01A_ASXL2_chr2_26101035_-_MORC3_chr21_37744672_length(amino acids)=169AA_start in transcript=153_stop in transcript=662 MLGCPPGLTSLFSHLSRHRGKSSAGQSRQGGRPEPGHGSLPVSSRPDMREKGRRKKGRTWAEAAKTVELLEMEKSQIRSQCEELKTEVEQ -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ASXL2-MORC3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ASXL2-MORC3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ASXL2-MORC3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ASXL2 | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human |
Hgene | ASXL2 | C0005695 | Bladder Neoplasm | 1 | CTD_human |
Hgene | ASXL2 | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
Hgene | ASXL2 | C0026998 | Acute Myeloid Leukemia, M1 | 1 | CTD_human |
Hgene | ASXL2 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 1 | CTD_human |
Hgene | ASXL2 | C4310672 | SHASHI-PENA SYNDROME | 1 | GENOMICS_ENGLAND |